Page 11 - Michael Castagna News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael castagna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Castagna Today - Breaking & Trending Today

Profund Advisors LLC Invests $1.05 Million in MannKind Co. (NASDAQ:MNKD)

Profund Advisors LLC acquired a new position in MannKind Co. (NASDAQ:MNKD – Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 256,293 shares of the biopharmaceutical company’s stock, valued at approximately $1,051,000. A number of other hedge funds and […] ....

United States , David Thomson , Michael Castagna , Mannkind Corporation , American Century Companies Inc , Profund Advisors , Mannkind Co , Mannkind Company Profile , Raymond James Financial Services Advisors Inc , Cantor Fitzgerald , American International Group Inc , Securities Exchange Commission , Free Report , Wisconsin Investment Board , International Group , Century Companies , Raymond James Financial Services Advisors , James Financial Services Advisors , Exchange Commission , Get Free Report , Kind Corporation , Visit Holdingschannel , Mannkind Daily , Nasdaq Mnkd , Sec Filings , Hedge Fund Holdings ,

MannKind (NASDAQ:MNKD) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of MannKind (NASDAQ:MNKD – Free Report) in a report issued on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Other analysts have also recently issued research reports about the stock. Cantor Fitzgerald boosted their price target on shares of MannKind from $6.50 to $7.50 and […] ....

Michael Castagna , David Thomson , Alfrede Mann , Raymond James Associates , Hightower Advisors , Securities Exchange Commission , Cantor Fitzgerald , Us Bancorp , Raymond James Financial Services Advisors Inc , International Assets Investment Management , Mannkind Corp , Free Report , Exchange Commission , Assets Investment Management , James Financial Services Advisors , Tower Advisors , Get Free Report , Mannkind Daily , Nasdaq Mnkd , Initiated Coverage , Stocknews Com ,

MannKind (NASDAQ:MNKD) PT Raised to $7.50

MannKind (NASDAQ:MNKD) PT Raised to $7.50
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Michael Castagna , Stevenb Binder , Alfrede Mann , International Assets Investment Management , Us Bancorp , Mannkind Corp , Raymond James Financial Services Advisors Inc , Hightower Advisors , Mannkind Company Profile , Securities Exchange Commission , Cantor Fitzgerald , Raymond James Associates , Get Free Report , Kind Trading Down , Exchange Commission , Assets Investment Management , James Financial Services Advisors , Tower Advisors , Mannkind Daily ,

MannKind (NASDAQ:MNKD) PT Raised to $7.50

MannKind (NASDAQ:MNKD – Get Free Report) had its price target upped by investment analysts at Cantor Fitzgerald from $6.50 to $7.50 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has an “overweight” rating on the biopharmaceutical company’s stock. Cantor Fitzgerald’s target price indicates a potential upside of 41.78% from […] ....

Michael Castagna , Alfrede Mann , Stevenb Binder , Cantor Fitzgerald , Securities Exchange Commission , Cetera Advisor Networks , Topco Ltd , Mannkind Company Profile , First Horizon Advisors Inc , Mannkind Corp , Cetera Advisors , International Assets Investment Management , Get Free Report , Kind Stock Down , Exchange Commission , Assets Investment Management , Horizon Advisors , Mannkind Daily , Nasdaq Mnkd , Boost Price Target ,

MannKind (NASDAQ:MNKD) Price Target Increased to $7.50 by Analysts at Cantor Fitzgerald

MannKind (NASDAQ:MNKD – Get Free Report) had its target price upped by equities research analysts at Cantor Fitzgerald from $6.50 to $7.50 in a note issued to investors on Tuesday, Benzinga reports. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price target suggests a potential upside of 41.78% from […] ....

Michael Castagna , Stevenb Binder , Alfrede Mann , Proshare Advisors , Charles Schwab Investment Management Inc , Securities Exchange Commission , Great West Life Assurance Co , Cetera Advisors , Mannkind Corp , Cetera Advisor Networks , Mannkind Company Profile , Cantor Fitzgerald , Get Free Report , Exchange Commission , West Life Assurance , Share Advisors , Advisor Networks , Charles Schwab Investment Management , Schwab Investment Management , Mannkind Daily , Nasdaq Mnkd , Boost Price Target ,